{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T03:32:23Z","timestamp":1792985543577,"version":"4.5.0"},"reference-count":165,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T00:00:00Z","timestamp":1737936000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100018706","name":"HORIZON EUROPE Widening participation and spreading excellence","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018706","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["UIDB\/00511\/2020"],"award-info":[{"award-number":["UIDB\/00511\/2020"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["2023-Acess-02\/Horizon-CSA"],"award-info":[{"award-number":["2023-Acess-02\/Horizon-CSA"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["UIDB\/00081\/2020"],"award-info":[{"award-number":["UIDB\/00081\/2020"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["LA\/P\/0045\/2020"],"award-info":[{"award-number":["LA\/P\/0045\/2020"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["pharmrev.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Reviews"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.pharmr.2025.100038","type":"journal-article","created":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T11:35:25Z","timestamp":1736422525000},"page":"100038","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Polypharmacological strategies for infectious bacteria"],"prefix":"10.1016","volume":"77","author":[{"given":"Miguel M.","family":"Leit\u00e3o","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7408-1331","authenticated-orcid":false,"given":"Ariana S.C.","family":"Gon\u00e7alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda","family":"Borges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3355-4398","authenticated-orcid":false,"given":"Manuel","family":"Sim\u00f5es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6929-6805","authenticated-orcid":false,"given":"Anabela","family":"Borges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmr.2025.100038_bib1","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.jaad.2005.10.010","article-title":"Dermatologic side effects associated with the epidermal growth factor receptor inhibitors","volume":"55","author":"Agero","year":"2006","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.pharmr.2025.100038_bib2","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/1751-7915.12117","article-title":"Siderophores in environmental research: roles and applications","volume":"7","author":"Ahmed","year":"2014","journal-title":"Microb Biotechnol"},{"key":"10.1016\/j.pharmr.2025.100038_bib3","series-title":"Molecular Sciences and Chemical Engineering","article-title":"Strategy and tactics for designing analogs: biochemical characterization of the large molecules, In: Reedijk J., Reference Module in Chemistry","author":"Ahn","year":"2017"},{"key":"10.1016\/j.pharmr.2025.100038_bib4","first-page":"303","article-title":"Bacterial siderophore and their application: a review","volume":"2","author":"Ali","year":"2013","journal-title":"Int J Curr Microbiol Appl Sci"},{"key":"10.1016\/j.pharmr.2025.100038_bib5","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1517\/14728214.11.2.251","article-title":"Emerging therapies for the treatment and prevention of otitis media","volume":"11","author":"Aliphas","year":"2006","journal-title":"Expert Opin Emerg Drugs"},{"key":"10.1016\/j.pharmr.2025.100038_bib6","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/2049-632X.12015","article-title":"Eradication of Pseudomonas aeruginosa biofilms on cultured airway cells by a fosfomycin\/tobramycin antibiotic combination","volume":"67","author":"Anderson","year":"2013","journal-title":"Pathog Dis"},{"key":"10.1016\/j.pharmr.2025.100038_bib7","doi-asserted-by":"crossref","first-page":"7874","DOI":"10.1021\/jm5006463","article-title":"Polypharmacology: challenges and opportunities in drug discovery: miniperspective","volume":"57","author":"Anighoro","year":"2014","journal-title":"J\u00a0Med Chem"},{"key":"10.1016\/j.pharmr.2025.100038_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2022.129012","article-title":"Unique iminotetrahydroberberine-corbelled metronidazoles as potential membrane active broad-spectrum antibacterial agents","volume":"76","author":"Ansari","year":"2022","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.pharmr.2025.100038_bib9","doi-asserted-by":"crossref","first-page":"12661","DOI":"10.1021\/bi801597b","article-title":"The vancomycin\u2212 nisin (1\u2212 12) hybrid restores activity against vancomycin resistant Enterococci","volume":"47","author":"Arnusch","year":"2008","journal-title":"Biochemistry"},{"key":"10.1016\/j.pharmr.2025.100038_bib10","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jgar.2017.03.006","article-title":"Inhibition of Pseudomonas aeruginosa quorum sensing by subinhibitory concentrations of curcumin with gentamicin and azithromycin","volume":"10","author":"Bahari","year":"2017","journal-title":"J Glob Antimicrob Resist"},{"key":"10.1016\/j.pharmr.2025.100038_bib11","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1093\/jac\/dkt401","article-title":"Cadazolid, a novel antibiotic with potent activity against Clostridium difficile: safety, tolerability and pharmacokinetics in healthy subjects following single and multiple oral doses","volume":"69","author":"Baldoni","year":"2013","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.pharmr.2025.100038_bib12","doi-asserted-by":"crossref","first-page":"9057","DOI":"10.1002\/anie.201202414","article-title":"Cephalosporin-3\u2032-diazeniumdiolates: targeted NO-donor prodrugs for dispersing bacterial biofilms","volume":"51","author":"Barraud","year":"2012","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1016\/j.pharmr.2025.100038_bib13","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1517\/17425250903145251","article-title":"Ampicillin-sulbactam: an update on the use of parenteral and oral forms in bacterial infections","volume":"5","author":"Betrosian","year":"2009","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.pharmr.2025.100038_bib14","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1128\/AAC.05532-11","article-title":"Antistaphylococcal activity of TD-1792, a multivalent glycopeptide-cephalosporin antibiotic","volume":"56","author":"Blais","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.pharmr.2025.100038_bib15","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1002\/cmdc.201600161","article-title":"Multitarget drug discovery and polypharmacology","volume":"11","author":"Bolognesi","year":"2016","journal-title":"ChemMedChem"},{"key":"10.1016\/j.pharmr.2025.100038_bib16","doi-asserted-by":"crossref","first-page":"877","DOI":"10.3390\/molecules21070877","article-title":"New perspectives on the use of phytochemicals as an emergent strategy to control bacterial infections including biofilms","volume":"21","author":"Borges","year":"2016","journal-title":"Molecules"},{"key":"10.1016\/j.pharmr.2025.100038_bib17","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.2174\/0929867322666150530210522","article-title":"Insights on antimicrobial resistance, biofilms and the use of phytochemicals as new antimicrobial agents","volume":"22","author":"Borges","year":"2015","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.pharmr.2025.100038_bib18","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1078\/1438-4221-00103","article-title":"Iron uptake mechanisms and their regulation in pathogenic bacteria","volume":"291","author":"Braun","year":"2001","journal-title":"Int J Med Microbiol"},{"key":"10.1016\/j.pharmr.2025.100038_bib19","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.cbpa.2011.01.005","article-title":"Recent insights into iron import by bacteria","volume":"15","author":"Braun","year":"2011","journal-title":"Curr Opin Chem Biol"},{"key":"10.1016\/j.pharmr.2025.100038_bib20","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a025247","article-title":"\u03b2-Lactams and \u03b2-lactamase inhibitors: an overview","volume":"6","author":"Bush","year":"2016","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.pharmr.2025.100038_bib21","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1002\/phar.2034","article-title":"Early administration of adjuvant \u03b2-lactam therapy in combination with vancomycin among patients with methicillin-resistant Staphylococcus aureus bloodstream infection: a retrospective, multicenter analysis","volume":"37","author":"Casapao","year":"2017","journal-title":"Pharmacother J Hum Pharmacol Drug Ther"},{"key":"10.1016\/j.pharmr.2025.100038_bib22","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1080\/17460441.2020.1767063","article-title":"An up-to-date overview of computational polypharmacology in modern drug discovery","volume":"15","author":"Chaudhari","year":"2020","journal-title":"Expert Opin Drug Discov"},{"key":"10.1016\/j.pharmr.2025.100038_bib23","article-title":"Baicalein inhibits Staphylococcus aureus biofilm formation and the quorum sensing system in vitro","volume":"11","author":"Chen","year":"2016","journal-title":"PLOS ONE"},{"key":"10.1016\/j.pharmr.2025.100038_bib24","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1093\/jac\/dkg003","article-title":"Pharmacokinetics of intravenous azithromycin and ceftriaxone when administered alone and concurrently to healthy volunteers","volume":"50","author":"Chiu","year":"2002","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.pharmr.2025.100038_bib25","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1128\/MMBR.65.2.232-260.2001","article-title":"Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance","volume":"65","author":"Chopra","year":"2001","journal-title":"Microbiol Mol Biol Rev"},{"key":"10.1016\/j.pharmr.2025.100038_bib26","doi-asserted-by":"crossref","first-page":"9779","DOI":"10.1021\/acs.jmedchem.5b01578","article-title":"Synthesis of tridecaptin\u2013antibiotic conjugates with in\u00a0vivo activity against gram-negative bacteria","volume":"58","author":"Cochrane","year":"2015","journal-title":"J\u00a0Med Chem"},{"key":"10.1016\/j.pharmr.2025.100038_bib27","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ijmm.2013.02.009","article-title":"Intrinsic antibiotic resistance: mechanisms, origins, challenges and solutions","volume":"303","author":"Cox","year":"2013","journal-title":"Int J Med Microbiol"},{"key":"10.1016\/j.pharmr.2025.100038_bib28","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/(SICI)1098-0997(1996)4:5<258::AID-IDOG3>3.0.CO;2-U","article-title":"Piperacillin\/tazobactam (ZOSYN)","volume":"4","author":"Culver","year":"1996","journal-title":"Infect Dis Obstet Gynecol"},{"key":"10.1016\/j.pharmr.2025.100038_bib29","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00181-19","article-title":"Antimicrobial resistance in ESKAPE pathogens","volume":"33","author":"De Oliveira","year":"2020","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.pharmr.2025.100038_bib30","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1007\/s40265-018-0966-7","article-title":"Meropenem\/vaborbactam: a review in complicated urinary tract infections","volume":"78","author":"Dhillon","year":"2018","journal-title":"Drugs"},{"key":"10.1016\/j.pharmr.2025.100038_bib31","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00077-17","article-title":"Antibiotic hybrids: the next generation of agents and adjuvants against gram-negative pathogens?","volume":"31","author":"Domalaon","year":"2018","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.pharmr.2025.100038_bib32","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/S1369-5274(99)00008-9","article-title":"Mechanism of fluoroquinolone action","volume":"2","author":"Drlica","year":"1999","journal-title":"Curr Opin Microbiol"},{"key":"10.1016\/j.pharmr.2025.100038_bib33","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.intimp.2005.01.007","article-title":"Effects of a short-course of amoxicillin\/clavulanic acid on systemic and mucosal immunity in healthy adult humans","volume":"5","author":"Dufour","year":"2005","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.pharmr.2025.100038_bib34","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1177\/1060028020929988","article-title":"Cefiderocol: a siderophore cephalosporin","volume":"54","author":"El-Lababidi","year":"2020","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.pharmr.2025.100038_bib35","article-title":"Meropenem and vaborbactam injection (vabomere)","volume":"39","author":"Elliott","year":"2017","journal-title":"Intern Med Alert"},{"key":"10.1016\/j.pharmr.2025.100038_bib36","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1093\/cid\/ciaa586","article-title":"Efficacy of ceftazidime-avibactam plus aztreonam in patients with bloodstream infections caused by metallo-\u03b2-lactamase\u2013producing Enterobacterales","volume":"72","author":"Falcone","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.pharmr.2025.100038_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3000856","article-title":"CombiANT: Antibiotic interaction testing made easy","volume":"18","author":"Fatsis-Kavalopoulos","year":"2020","journal-title":"PLOS Biol"},{"key":"10.1016\/j.pharmr.2025.100038_bib38","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/MRM.0b013e3283587727","article-title":"\u03b2-Lactams: chemical structure, mode of action and mechanisms of resistance","volume":"24","author":"Fernandes","year":"2013","journal-title":"Rev Res Med Microbiol"},{"key":"10.1016\/j.pharmr.2025.100038_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.diagmicrobio.2020.115040","article-title":"In\u00a0vitro activity of TNP-2092 against periprosthetic joint infection\u2013associated staphylococci","volume":"97","author":"Fisher","year":"2020","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.pharmr.2025.100038_bib40","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/nchembio817","article-title":"Systems biology and combination therapy in the quest for clinical efficacy","volume":"2","author":"Fitzgerald","year":"2006","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.pharmr.2025.100038_bib41","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ejmech.2017.05.016","article-title":"Designing multi-targeted agents: An emerging anticancer drug discovery paradigm","volume":"136","author":"Fu","year":"2017","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.pharmr.2025.100038_bib42","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1039\/C5MD00344J","article-title":"Mechanisms of resistance to aminoglycoside antibiotics: overview and perspectives","volume":"7","author":"Garneau-Tsodikova","year":"2016","journal-title":"MedChemComm"},{"key":"10.1016\/j.pharmr.2025.100038_bib43","doi-asserted-by":"crossref","first-page":"949","DOI":"10.2174\/1568026033452159","article-title":"Macrolide antibiotics: binding site, mechanism of action, resistance","volume":"3","author":"Gaynor","year":"2003","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/j.pharmr.2025.100038_bib44","doi-asserted-by":"crossref","first-page":"663","DOI":"10.3390\/pathogens11060663","article-title":"Recent advances in the use of molecular methods for the diagnosis of bacterial infections","volume":"11","author":"Gerace","year":"2022","journal-title":"Pathogens"},{"key":"10.1016\/j.pharmr.2025.100038_bib45","doi-asserted-by":"crossref","first-page":"79","DOI":"10.5799\/ahinjs.02.2012.03.0049","article-title":"Clinical profile of patients treated with cefepime\/tazobactam: A new \u00df-lactam-\u00df-lactamase inhibitor combination","volume":"2","author":"Ghafur","year":"2012","journal-title":"J\u00a0Microbiol Infect Dis"},{"key":"10.1016\/j.pharmr.2025.100038_bib46","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/cbdd.12478","article-title":"Antibiotic adjuvants: diverse strategies for controlling drug-resistant pathogens","volume":"85","author":"Gill","year":"2015","journal-title":"Chem Biol Drug Des"},{"key":"10.1016\/j.pharmr.2025.100038_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.jphotobiol.2024.112978","article-title":"Photodynamic activation of phytochemical-antibiotic combinations for combatting Staphylococcus aureus from acute wound infections","volume":"258","author":"Gon\u00e7alves","year":"2024","journal-title":"J Photochem Photobiol B"},{"key":"10.1016\/j.pharmr.2025.100038_bib48","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1039\/D2NP00053A","article-title":"The action of phytochemicals in biofilm control","volume":"40","author":"Gon\u00e7alves","year":"2023","journal-title":"Nat Prod Rep"},{"key":"10.1016\/j.pharmr.2025.100038_bib49","doi-asserted-by":"crossref","first-page":"4221","DOI":"10.1016\/j.bmcl.2017.08.027","article-title":"Antibiotic adjuvants\u2013A strategy to unlock bacterial resistance to antibiotics","volume":"27","author":"Gonz\u00e1lez-Bello","year":"2017","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.pharmr.2025.100038_bib50","doi-asserted-by":"crossref","first-page":"8441","DOI":"10.1021\/acs.jmedchem.6b00867","article-title":"Hybrid antibiotic overcomes resistance in P. aeruginosa by enhancing outer membrane penetration and reducing efflux","volume":"59","author":"Gorityala","year":"2016","journal-title":"J Med Chem"},{"key":"10.1016\/j.pharmr.2025.100038_bib51","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.tips.2014.06.007","article-title":"Siderophore\u2013drug complexes: potential medicinal applications of the \u2018Trojan horse\u2019strategy","volume":"35","author":"G\u00f3rska","year":"2014","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pharmr.2025.100038_bib52","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1021\/acsinfecdis.0c00001","article-title":"Multitarget approaches against multiresistant superbugs","volume":"6","author":"Gray","year":"2020","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.pharmr.2025.100038_bib53","doi-asserted-by":"crossref","first-page":"97","DOI":"10.4103\/ijmr.IJMR_755_18","article-title":"Next-generation strategy for treating drug resistant bacteria: Antibiotic hybrids","volume":"149","author":"Gupta","year":"2019","journal-title":"Ind J Med Res"},{"key":"10.1016\/j.pharmr.2025.100038_bib54","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3390\/antibiotics2010028","article-title":"Recent advances in multi-drug resistance (MDR) efflux pump inhibitors of gram-positive bacteria S. aureus","volume":"2","author":"Handzlik","year":"2013","journal-title":"Antibiotics"},{"key":"10.1016\/j.pharmr.2025.100038_bib55","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1093\/bib\/bbr011","article-title":"Old friends in new guise: repositioning of known drugs with structural bioinformatics","volume":"12","author":"Haupt","year":"2011","journal-title":"Brief Bioinform"},{"key":"10.1016\/j.pharmr.2025.100038_bib56","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s40265-021-01471-8","article-title":"Imipenem\/cilastatin\/relebactam: a review in gram-negative bacterial infections","volume":"81","author":"Heo","year":"2021","journal-title":"Drugs"},{"key":"10.1016\/j.pharmr.2025.100038_bib57","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1086\/656788","article-title":"Colistin-Tobramycin combinations are superior to monotherapy concerning the killing of biofilm Pseudomonas aeruginosa","volume":"202","author":"Herrmann","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.pharmr.2025.100038_bib58","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.4155\/fmc-2017-0294","article-title":"The polypharmacology of natural products","volume":"10","author":"Ho","year":"2018","journal-title":"Future Med Chem"},{"key":"10.1016\/j.pharmr.2025.100038_bib59","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1038\/nbt1007-1110","article-title":"Network pharmacology","volume":"25","author":"Hopkins","year":"2007","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.pharmr.2025.100038_bib60","doi-asserted-by":"crossref","first-page":"144","DOI":"10.12688\/f1000research.2-144.v1","article-title":"High-resolution view of compound promiscuity","volume":"2","author":"Hu","year":"2013","journal-title":"F1000Res"},{"key":"10.1016\/j.pharmr.2025.100038_bib61","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/BF02098092","article-title":"Synergism of trimethoprim and ciprofloxacin in\u00a0vitro against clinical bacterial isolates","volume":"11","author":"Huovinen","year":"1992","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.pharmr.2025.100038_bib62","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1093\/jac\/dkz228","article-title":"Potentiation of \u03b2-lactam antibiotics and \u03b2-lactam\/\u03b2-lactamase inhibitor combinations against MDR and XDR Pseudomonas aeruginosa using non-ribosomal tobramycin\u2013cyclam conjugates","volume":"74","author":"Idowu","year":"2019","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.pharmr.2025.100038_bib63","doi-asserted-by":"crossref","first-page":"4384","DOI":"10.1128\/AAC.03098-15","article-title":"Stability of novel siderophore cephalosporin S-649266 against clinically relevant carbapenemases","volume":"60","author":"Ito-Horiyama","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.pharmr.2025.100038_bib64","doi-asserted-by":"crossref","first-page":"S120","DOI":"10.1086\/428052","article-title":"Mechanisms of resistance to quinolones","volume":"41","author":"Jacoby","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.pharmr.2025.100038_bib65","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1080\/03009734.2016.1195900","article-title":"Antimicrobial resistance\u2014a threat to the world\u2019s sustainable development","volume":"121","author":"Jasovsk\u00fd","year":"2016","journal-title":"Upsala J Med Sci"},{"key":"10.1016\/j.pharmr.2025.100038_bib66","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1093\/jac\/46.6.973","article-title":"Antagonism between penicillin and erythromycin against Streptococcus pneumoniae in vitro and in vivo","volume":"46","author":"Johansen","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.pharmr.2025.100038_bib67","doi-asserted-by":"crossref","DOI":"10.1093\/femspd\/ftw019","article-title":"Rifampicin-containing combinations are superior to combinations of vancomycin, linezolid and daptomycin against Staphylococcus aureus biofilm infection in vivo and in vitro","volume":"74","author":"J\u00f8rgensen","year":"2016","journal-title":"Pathog Dis"},{"key":"10.1016\/j.pharmr.2025.100038_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.106055","article-title":"Polypharmacology: the science of multi-targeting molecules","volume":"176","author":"Kabir","year":"2022","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.pharmr.2025.100038_bib69","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1002\/jcph.841","article-title":"Cefiderocol, a siderophore cephalosporin for gram-negative bacterial infections: pharmacokinetics and safety in subjects with renal impairment","volume":"57","author":"Katsube","year":"2017","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100038_bib70","doi-asserted-by":"crossref","first-page":"e01381","DOI":"10.1128\/AAC.01381-16","article-title":"Pharmacokinetic\/pharmacodynamic modeling and simulation of cefiderocol, a parenteral siderophore cephalosporin, for dose adjustment based on renal function","volume":"61","author":"Katsube","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.pharmr.2025.100038_bib71","doi-asserted-by":"crossref","first-page":"44","DOI":"10.61186\/mlj.15.5.44","article-title":"Siderophore: a suitable candidate for drug delivery using the trojan horse strategy","volume":"15","author":"Khasheii","year":"2021","journal-title":"Med Lab J"},{"key":"10.1016\/j.pharmr.2025.100038_bib72","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1039\/C7NP00006E","article-title":"Bifunctional antimicrobial conjugates and hybrid antimicrobials","volume":"34","author":"Klahn","year":"2017","journal-title":"Nat Prod Rep"},{"key":"10.1016\/j.pharmr.2025.100038_bib73","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1016\/j.bbamem.2007.07.026","article-title":"Structural biology of bacterial iron uptake","volume":"1778","author":"Krewulak","year":"2008","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.pharmr.2025.100038_bib74","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1002\/med.21591","article-title":"Efflux pump inhibitors of clinically relevant multidrug resistant bacteria","volume":"39","author":"Lamut","year":"2019","journal-title":"Med Res Rev"},{"key":"10.1016\/j.pharmr.2025.100038_bib75","doi-asserted-by":"crossref","first-page":"7505","DOI":"10.1002\/slct.202101364","article-title":"Assessment of dihydro [1, 3] oxazine-fused isoflavone and 4-thionoisoflavone hybrids as antibacterials","volume":"6","author":"Lathwal","year":"2021","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.pharmr.2025.100038_bib76","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.eimc.2021.12.008","article-title":"Ceftolozane\/tazobactam for the treatment of Pseudomonas aeruginosa infections: A multicenter case series analysis","volume":"41","author":"Leit\u00e3o","year":"2023","journal-title":"Enferm Infecc Microbiol Clin (Engl)"},{"key":"10.1016\/j.pharmr.2025.100038_bib77","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2024.106663","article-title":"Dual action of benzaldehydes: inhibiting quorum sensing and enhancing antibiotic efficacy for controlling Pseudomonas aeruginosa biofilms","volume":"191","author":"Leit\u00e3o","year":"2024","journal-title":"Microb Pathog"},{"key":"10.1016\/j.pharmr.2025.100038_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.105718","article-title":"Novel metronidazole-derived three-component hybrids as promising broad-spectrum agents to combat oppressive bacterial resistance","volume":"122","author":"Li","year":"2022","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.pharmr.2025.100038_bib79","first-page":"288","article-title":"Dynamic covalent nano-networks comprising antibiotics and polyphenols orchestrate bacterial drug resistance reversal and inflammation alleviation","volume":"27","author":"Li","year":"2023","journal-title":"Bioact Mater"},{"key":"10.1016\/j.pharmr.2025.100038_bib80","doi-asserted-by":"crossref","first-page":"ii9","DOI":"10.1093\/jac\/dkg249","article-title":"Linezolid in\u00a0vitro: mechanism and antibacterial spectrum","volume":"51","author":"Livermore","year":"2003","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.pharmr.2025.100038_bib81","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1128\/AAC.01830-13","article-title":"In vitro and in vivo antibacterial evaluation of cadazolid, a new antibiotic for treatment of Clostridium difficile infections","volume":"58","author":"Locher","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.pharmr.2025.100038_bib82","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1128\/AAC.45.1.105-116.2001","article-title":"Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: novel agents for combination therapy","volume":"45","author":"Lomovskaya","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.pharmr.2025.100038_bib83","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.1021\/acs.jmedchem.6b01742","article-title":"Amphiphilic tobramycin\u2013lysine conjugates sensitize multidrug resistant gram-negative bacteria to rifampicin and minocycline","volume":"60","author":"Lyu","year":"2017","journal-title":"J\u00a0Med Chem"},{"key":"10.1016\/j.pharmr.2025.100038_bib84","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.ejmech.2017.11.049","article-title":"Exploiting polypharmacology for improving therapeutic outcome of kinase inhibitors (KIs): an update of recent medicinal chemistry efforts","volume":"143","author":"Ma","year":"2018","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.pharmr.2025.100038_bib85","doi-asserted-by":"crossref","first-page":"6645","DOI":"10.1021\/acs.jmedchem.6b00485","article-title":"Development of a dual-acting antibacterial agent (TNP-2092) for the treatment of persistent bacterial infections","volume":"59","author":"Ma","year":"2016","journal-title":"J\u00a0Med Chem"},{"key":"10.1016\/j.pharmr.2025.100038_bib86","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1080\/00397911.2017.1397698","article-title":"Design, synthesis, characterization, and biological evaluation of pyrido [1, 2-a] pyrimidinone coumarins as promising anti-inflammatory agents","volume":"48","author":"Madar","year":"2018","journal-title":"Synth Commun"},{"key":"10.1016\/j.pharmr.2025.100038_bib87","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1517\/14740338.2013.827660","article-title":"Clinical consequences of polypharmacy in elderly","volume":"13","author":"Maher","year":"2014","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.pharmr.2025.100038_bib88","first-page":"170","article-title":"Structural hybridization of three aminoglycoside antibiotics yields a potent broad-spectrum bactericide that eludes bacterial resistance enzymes","volume":"7","author":"Maianti","year":"2016","journal-title":"Med Chem"},{"key":"10.1016\/j.pharmr.2025.100038_bib89","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.2147\/DDDT.S257494","article-title":"Potential impact of the multi-target drug approach in the treatment of some complex diseases","volume":"14","author":"Makhoba","year":"2020","journal-title":"Drug Des Dev Ther"},{"key":"10.1016\/j.pharmr.2025.100038_bib90","series-title":"Drug Selectivity: an Evolving Concept in Medicinal Chemistry","first-page":"1","article-title":"Polypharmacology in drug discovery","author":"M\u00e9ndez-Lucio","year":"2018"},{"key":"10.1016\/j.pharmr.2025.100038_bib91","series-title":"Drug Selectivity: an Evolving Concept in Medicinal Chemistry","article-title":"The Linker Approach","author":"Merk","year":"2017"},{"key":"10.1016\/j.pharmr.2025.100038_bib92","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1128\/MMBR.00012-07","article-title":"Siderophore-based iron acquisition and pathogen control","volume":"71","author":"Miethke","year":"2007","journal-title":"Microbiol Mol Biol Rev"},{"key":"10.1016\/j.pharmr.2025.100038_bib93","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/s41570-021-00313-1","article-title":"Towards the sustainable discovery and development of new antibiotics","volume":"5","author":"Miethke","year":"2021","journal-title":"Nat Rev Chem"},{"key":"10.1016\/j.pharmr.2025.100038_bib94","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1007\/s10156-002-0186-6","article-title":"Role of fosfomycin in a synergistic combination with ofloxacin against Pseudomonas aeruginosa growing in a biofilm","volume":"8","author":"Monden","year":"2002","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.pharmr.2025.100038_bib95","doi-asserted-by":"crossref","first-page":"6523","DOI":"10.1021\/jm058225d","article-title":"Designed multiple ligands. An emerging drug discovery paradigm","volume":"48","author":"Morphy","year":"2005","journal-title":"J\u00a0Med Chem"},{"key":"10.1016\/j.pharmr.2025.100038_bib96","doi-asserted-by":"crossref","first-page":"4961","DOI":"10.1021\/jm0603015","article-title":"The physicochemical challenges of designing multiple ligands","volume":"49","author":"Morphy","year":"2006","journal-title":"J\u00a0Med Chem"},{"key":"10.1016\/j.pharmr.2025.100038_bib97","first-page":"479","article-title":"Ceftazidime-avibactam (Avycaz): for the treatment of complicated intra-abdominal and urinary tract infections","volume":"41","author":"Mosley","year":"2016","journal-title":"Pharm Ther"},{"key":"10.1016\/j.pharmr.2025.100038_bib98","doi-asserted-by":"crossref","first-page":"539","DOI":"10.3389\/fmicb.2019.00539","article-title":"Emerging strategies to combat ESKAPE pathogens in the era of antimicrobial resistance: a review","volume":"10","author":"Mulani","year":"2019","journal-title":"Front Microbiol"},{"key":"10.1016\/j.pharmr.2025.100038_bib99","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/nmat3776","article-title":"Stimuli-responsive nanocarriers for drug delivery","volume":"12","author":"Mura","year":"2013","journal-title":"Nat Mater"},{"key":"10.1016\/j.pharmr.2025.100038_bib100","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.1021\/acs.molpharmaceut.3c00095","article-title":"Simple and efficient synthesis of 3-aryl-2-oxazolidinone scaffolds enabling increased potency toward biofilms","volume":"20","author":"Ndukwe","year":"2023","journal-title":"Mol Pharm"},{"key":"10.1016\/j.pharmr.2025.100038_bib101","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1128\/AAC.14.5.650","article-title":"Clavulanic acid, a novel inhibitor of \u03b2-lactamases","volume":"14","author":"Neu","year":"1978","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.pharmr.2025.100038_bib102","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/nbt1519","article-title":"Protein promiscuity and its implications for biotechnology","volume":"27","author":"Nobeli","year":"2009","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.pharmr.2025.100038_bib103","doi-asserted-by":"crossref","first-page":"523","DOI":"10.2165\/00044011-200424090-00003","volume":"24","author":"Notivol","year":"2004","journal-title":"Clin Drug Investig"},{"key":"10.1016\/j.pharmr.2025.100038_bib104","author":"O'Neill"},{"key":"10.1016\/j.pharmr.2025.100038_bib105","doi-asserted-by":"crossref","first-page":"4573","DOI":"10.1128\/AAC.02463-14","article-title":"Antagonism between bacteriostatic and bactericidal antibiotics is prevalent","volume":"58","author":"Ocampo","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.pharmr.2025.100038_bib106","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1128\/AAC.01525-09","article-title":"In\u00a0vitro properties of BAL30072, a novel siderophore sulfactam with activity against multiresistant gram-negative bacilli","volume":"54","author":"Page","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.pharmr.2025.100038_bib107","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.tim.2015.02.009","article-title":"Collateral sensitivity of antibiotic-resistant microbes","volume":"23","author":"P\u00e1l","year":"2015","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.pharmr.2025.100038_bib108","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003803","article-title":"The TFPI-2 derived peptide EDC34 improves outcome of gram-negative sepsis","volume":"9","author":"Papareddy","year":"2013","journal-title":"PLOS Pathog"},{"key":"10.1016\/j.pharmr.2025.100038_bib109","doi-asserted-by":"crossref","first-page":"51","DOI":"10.12771\/emj.2002.25.2.51","article-title":"A\u00a0comparative study of the clinical efficacy and safety of amoxicillin-sulbactam (Sultamox\u00ae) and amoxicillin-clavulanic acid (Augmentin\u00ae) in the treatment of bronchial asthma with mixed infection","volume":"25","author":"Park","year":"2002","journal-title":"EWHA Med"},{"key":"10.1016\/j.pharmr.2025.100038_bib110","first-page":"962","article-title":"Enhancing antibiotic efficacy in regenerative endodontics by improving biofilm susceptibility","volume":"50","author":"Pereira","year":"2024","journal-title":"J\u00a0Endod"},{"key":"10.1016\/j.pharmr.2025.100038_bib111","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232214291","article-title":"New chalcone\u2013triazole hybrids with promising antimicrobial activity in multidrug resistance strains","volume":"23","author":"Pereira","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.pharmr.2025.100038_bib112","doi-asserted-by":"crossref","first-page":"8955","DOI":"10.1021\/jm400856t","article-title":"Polypharmacology\u2013foe or friend?","volume":"56","author":"Peters","year":"2013","journal-title":"J\u00a0Med Chem"},{"key":"10.1016\/j.pharmr.2025.100038_bib113","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1517\/17460441.2010.508069","article-title":"Dual-acting hybrid antibiotics: a promising strategy to combat bacterial resistance","volume":"5","author":"Pokrovskaya","year":"2010","journal-title":"Expert Opin Drug Discov"},{"key":"10.1016\/j.pharmr.2025.100038_bib114","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1021\/jm900028n","article-title":"Design, synthesis, and evaluation of novel fluoroquinolone\u2212 aminoglycoside hybrid antibiotics","volume":"52","author":"Pokrovskaya","year":"2009","journal-title":"J\u00a0Med Chem"},{"key":"10.1016\/j.pharmr.2025.100038_bib115","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1016\/0926-9959(96)00027-X","article-title":"Comparative efficacy and tolerability of fusidic acid\/hydrocortisone cream (Fucidin\u00ae H cream) and miconazole\/hydrocortisone cream (Daktacort\u00ae cream) in infected eczema","volume":"7","author":"Poyner","year":"1996","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.pharmr.2025.100038_bib116","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/S1357-2725(00)00042-X","article-title":"The effects of salicylate on bacteria","volume":"32","author":"Price","year":"2000","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.pharmr.2025.100038_bib117","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1021\/acs.jmedchem.8b00760","article-title":"Polypharmacology by design: a medicinal chemist\u2019s perspective on multitargeting compounds","volume":"62","author":"Proschak","year":"2019","journal-title":"J\u00a0Med Chem"},{"key":"10.1016\/j.pharmr.2025.100038_bib118","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3389\/fphar.2015.00157","article-title":"Computational polypharmacology comes of age","volume":"6","author":"Rastelli","year":"2015","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100038_bib119","first-page":"DC01","article-title":"Impact of efflux pump inhibitor carbonyl cyanide m-chlorophenylhydrazone in multidrug resistant Acinetobacter species isolates from sterile body fluids","volume":"14","author":"Raza","year":"2020","journal-title":"J\u00a0Clin Diagnostic Res"},{"key":"10.1016\/j.pharmr.2025.100038_bib120","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1080\/21505594.2017.1313372","article-title":"Strategies for combating bacterial biofilms: A focus on anti-biofilm agents and their mechanisms of action","volume":"9","author":"Roy","year":"2018","journal-title":"Virulence"},{"key":"10.1016\/j.pharmr.2025.100038_bib121","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.amjms.2022.06.001","article-title":"Vancomycin-clindamycin combination therapy for the treatment of gram-positive infections, in-vitro antagonism vs. clinical benefits","volume":"365","author":"Sahraei","year":"2023","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.pharmr.2025.100038_bib122","doi-asserted-by":"crossref","first-page":"614","DOI":"10.3390\/life14050614","article-title":"Imipenem\/cilastatin\/relebactam for complicated infections: a real-world evidence","volume":"14","author":"Sansone","year":"2024","journal-title":"Life"},{"key":"10.1016\/j.pharmr.2025.100038_bib123","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jaad.2005.10.004","article-title":"Tetracyclines: nonantibiotic properties and their clinical implications","volume":"54","author":"Sapadin","year":"2006","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.pharmr.2025.100038_bib124","doi-asserted-by":"crossref","first-page":"S538","DOI":"10.1093\/cid\/ciz826","article-title":"Cefiderocol: discovery, chemistry, and in\u00a0vivo profiles of a novel siderophore cephalosporin","volume":"69","author":"Sato","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.pharmr.2025.100038_bib125","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.cmi.2018.03.037","article-title":"Siderophore\u2013antibiotic conjugates: exploiting iron uptake to deliver drugs into bacteria","volume":"24","author":"Schalk","year":"2018","journal-title":"Clini Microbiol Infect"},{"key":"10.1016\/j.pharmr.2025.100038_bib126","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2019.08.025","article-title":"Synthesis of new triazole fused imidazo [2, 1-b] thiazole hybrids with emphasis on Staphylococcus aureus virulence factors","volume":"29","author":"Shareef","year":"2019","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.pharmr.2025.100038_bib127","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1134\/S0006297920110085","article-title":"Next-generation antibiotics, bacteriophage endolysins, and nanomaterials for combating pathogens","volume":"85","author":"Shemyakin","year":"2020","journal-title":"Biochemistry (Mosc)"},{"key":"10.1016\/j.pharmr.2025.100038_bib128","series-title":"Polypharmacology in Drug Discovery","article-title":"Polypharmacology as an emerging trend in antibacterial discovery","author":"Silver","year":"2012"},{"key":"10.1016\/j.pharmr.2025.100038_bib129","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1054\/drup.2000.0146","article-title":"Sulfonamide resistance: mechanisms and trends","volume":"3","author":"Sk\u00f6ld","year":"2000","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.pharmr.2025.100038_bib130","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1128\/AAC.04974-14","article-title":"Effects of azithromycin, metronidazole, amoxicillin, and metronidazole plus amoxicillin on an in\u00a0vitro polymicrobial subgingival biofilm model","volume":"59","author":"Soares","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.pharmr.2025.100038_bib131","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/jac\/dkz378","article-title":"Cephalosporin nitric oxide-donor prodrug DEA-C3D disperses biofilms formed by clinical cystic fibrosis isolates of Pseudomonas aeruginosa","volume":"75","author":"Soren","year":"2020","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.pharmr.2025.100038_bib132","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.3390\/molecules25051239","article-title":"Multitargeting compounds: a promising strategy to overcome multi-drug resistant tuberculosis","volume":"25","author":"Stelitano","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.pharmr.2025.100038_bib133","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nmicrobiol.2017.28","article-title":"Pentamidine sensitizes Gram-negative pathogens to antibiotics and overcomes acquired colistin resistance","volume":"2","author":"Stokes","year":"2017","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.pharmr.2025.100038_bib134","doi-asserted-by":"crossref","first-page":"5476","DOI":"10.1128\/AAC.00712-12","article-title":"TD-1792 versus vancomycin for treatment of complicated skin and skin structure infections","volume":"56","author":"Stryjewski","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.pharmr.2025.100038_bib135","article-title":"Fused benzo [1, 3] thiazine-1, 2, 3-triazole hybrids: microwave-assisted one-pot synthesis, in\u00a0vitro antibacterial, antibiofilm, and in silico ADME studies","volume":"47","author":"Sucharitha","year":"2021","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.pharmr.2025.100038_bib136","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.112025","article-title":"Dual-target kinase drug design: Current strategies and future directions in cancer therapy","volume":"188","author":"Sun","year":"2020","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.pharmr.2025.100038_bib137","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0147698","article-title":"Impact of azithromycin on the quorum sensing-controlled proteome of Pseudomonas aeruginosa","volume":"11","author":"Swatton","year":"2016","journal-title":"PLOS ONE"},{"key":"10.1016\/j.pharmr.2025.100038_bib138","article-title":"Insights into newer antimicrobial agents against Gram-negative bacteria","volume":"9","author":"Taneja","year":"2016","journal-title":"Microbiol Insights"},{"key":"10.1016\/j.pharmr.2025.100038_bib139","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.cmi.2017.06.020","article-title":"Antibiotic innovation for future public health needs","volume":"23","author":"Theuretzbacher","year":"2017","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.pharmr.2025.100038_bib140","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1038\/s41564-020-0767-0","article-title":"Dual-mechanism antibiotics","volume":"5","author":"Theuretzbacher","year":"2020","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.pharmr.2025.100038_bib141","doi-asserted-by":"crossref","first-page":"264","DOI":"10.2165\/00003495-199039020-00008","article-title":"Amoxicillin\/clavulanic acid","volume":"39","author":"Todd","year":"1990","journal-title":"Drugs"},{"key":"10.1016\/j.pharmr.2025.100038_bib142","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0924-8579(01)00473-3","article-title":"Antimicrobial activities of clarithromycin, gatifloxacin and sitafloxacin, in combination with various antimycobacterial drugs against extracellular and intramacrophage Mycobacterium avium complex","volume":"19","author":"Tomioka","year":"2002","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.pharmr.2025.100038_bib143","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a025288","article-title":"Polymyxin: alternative mechanisms of action and resistance","volume":"6","author":"Trimble","year":"2016","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.pharmr.2025.100038_bib144","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1093\/jac\/19.3.313","article-title":"Comparative in-vitro activities of teicoplanin, vancomycin, coumermycin and ciprofloxacin, alone and in combination with rifampicin or LM 427, against Staphylococcus aureus","volume":"19","author":"Van der Auwera","year":"1987","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.pharmr.2025.100038_bib145","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.ejmech.2017.06.058","article-title":"Ciprofloxacin-nitroxide hybrids with potential for biofilm control","volume":"138","author":"Verderosa","year":"2017","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.pharmr.2025.100038_bib146","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01685-19","article-title":"Nitroxide functionalized antibiotics are promising eradication agents against Staphylococcus aureus biofilms","volume":"64","author":"Verderosa","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.pharmr.2025.100038_bib147","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1039\/C9MD00062C","article-title":"Eradicating uropathogenic Escherichia coli biofilms with a ciprofloxacin\u2013dinitroxide conjugate","volume":"10","author":"Verderosa","year":"2019","journal-title":"MedChemComm"},{"key":"10.1016\/j.pharmr.2025.100038_bib148","doi-asserted-by":"crossref","first-page":"841","DOI":"10.3390\/molecules21070841","article-title":"Synthesis and evaluation of ciprofloxacin-nitroxide conjugates as anti-biofilm agents","volume":"21","author":"Verderosa","year":"2016","journal-title":"Molecules"},{"key":"10.1016\/j.pharmr.2025.100038_bib149","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.648554","article-title":"Biofilm-innate immune interface: contribution to chronic wound formation","volume":"12","author":"Versey","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.pharmr.2025.100038_bib150","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1021\/acs.jmedchem.2c02044","article-title":"Design and synthesis of 3-hydroxy-pyridin-4 (1 H)-ones\u2013ciprofloxacin conjugates as dual antibacterial and antibiofilm agents against Pseudomonas aeruginosa","volume":"66","author":"Wang","year":"2023","journal-title":"J Med Chem"},{"key":"10.1016\/j.pharmr.2025.100038_bib151","doi-asserted-by":"crossref","first-page":"349","DOI":"10.2165\/00128071-200203050-00007","article-title":"Clindamycin\/benzoyl peroxide gel: a review of its use in the management of acne","volume":"3","author":"Warner","year":"2002","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.pharmr.2025.100038_bib152","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112931","article-title":"Polypharmacological drug actions of recently FDA approved antibiotics","volume":"209","author":"Wetzel","year":"2021","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.pharmr.2025.100038_bib153","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/j.1365-4362.1988.tb00936.x","article-title":"Topical mupiroccin versus topical neosporin in the treatment of cutaneous infections","volume":"27","author":"Wilkinson","year":"1988","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.pharmr.2025.100038_bib154","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1517\/13543784.12.2.117","article-title":"Novel agents for the treatment of resistant Gram-positive infections","volume":"12","author":"Woodford","year":"2003","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.pharmr.2025.100038_bib155","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.tibtech.2012.12.006","article-title":"Combination approaches to combat multidrug-resistant bacteria","volume":"31","author":"Worthington","year":"2013","journal-title":"Trends Biotechnol"},{"key":"10.1016\/j.pharmr.2025.100038_bib156","doi-asserted-by":"crossref","first-page":"7457","DOI":"10.1039\/c2ob25835h","article-title":"Small molecule control of bacterial biofilms","volume":"10","author":"Worthington","year":"2012","journal-title":"Org Biomol Chem"},{"key":"10.1016\/j.pharmr.2025.100038_bib157","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.tim.2016.06.009","article-title":"Antibiotic adjuvants: rescuing antibiotics from resistance","volume":"24","author":"Wright","year":"2016","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.pharmr.2025.100038_bib158","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1016\/j.biomaterials.2005.11.031","article-title":"Drug\/device combinations for local drug therapies and infection prophylaxis","volume":"27","author":"Wu","year":"2006","journal-title":"Biomaterials"},{"key":"10.1016\/j.pharmr.2025.100038_bib159","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ejmech.2014.04.037","article-title":"Design, synthesis, and evaluation of novel fluoroquinolone\u2013flavonoid hybrids as potent antibiotics against drug-resistant microorganisms","volume":"80","author":"Xiao","year":"2014","journal-title":"Eur Med Chem"},{"key":"10.1016\/j.pharmr.2025.100038_bib160","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1089\/mdr.2020.0178","article-title":"Synergistic antibacterial activity between 1,4-naphthoquinone and \u03b2-lactam antibiotics against methicillin-resistant Staphylococcus aureus","volume":"27","author":"Yap","year":"2021","journal-title":"Microb Drug Resist"},{"key":"10.1016\/j.pharmr.2025.100038_bib161","article-title":"The impact of concomitant empiric cefepime on patient outcomes of methicillin-resistant Staphylococcus aureus bloodstream infections treated with vancomycin","volume":"6","author":"Zasowski","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.pharmr.2025.100038_bib162","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a026989","article-title":"Approved glycopeptide antibacterial drugs: mechanism of action and resistance","volume":"6","author":"Zeng","year":"2016","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.pharmr.2025.100038_bib163","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202214299","article-title":"Antimicrobial hybrid amphiphile via dynamic covalent bonds enables bacterial biofilm dispersal and bacteria eradication","volume":"33","author":"Zhan","year":"2023","journal-title":"Adv Funct Materials"},{"key":"10.1016\/j.pharmr.2025.100038_bib164","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.2174\/1381612822666160224142812","article-title":"Polypharmacology in drug discovery: a review from systems pharmacology perspective","volume":"22","author":"Zhang","year":"2016","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.pharmr.2025.100038_bib165","doi-asserted-by":"crossref","first-page":"i457","DOI":"10.1093\/bioinformatics\/bty294","article-title":"Modeling polypharmacy side effects with graph convolutional networks","volume":"34","author":"Zitnik","year":"2018","journal-title":"Bioinformatics"}],"container-title":["Pharmacological Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003169972500002X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003169972500002X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T00:46:34Z","timestamp":1762217194000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S003169972500002X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":165,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S003169972500002X"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmr.2025.100038","relation":{},"ISSN":["0031-6997"],"issn-type":[{"value":"0031-6997","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Polypharmacological strategies for infectious bacteria","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmr.2025.100038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of American Society for Pharmacology and Experimental Therapeutics.","name":"copyright","label":"Copyright"}],"article-number":"100038"}}